_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

ONC20-C098(2)a November 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

...Show more

HCP20-C049 September 2020
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]